Currently, a drug called alteplase is used in thrombolysis, but the researchers think that another drug, called tenecteplase, may be more effective than alteplase.
A panel of independent experts has decided that alteplase, a clot-busting drug often used to treat strokes is safe and effective under current guidelines.
On Tuesday 1st September 2015, the Chief Scientist Office and the Stroke Association celebrated their partnership in building stroke research capacity in Scotland with the joint funding of two new research awards.
The ReTrain study is investigating the effectiveness of a community-based rehabilitation training programme for people who have suffered a stroke.
Today, the Chief Scientist Office and the Stroke Association celebrate a partnership that will build on the excellence of stroke research in Scotland.
The Stroke Association held this workshop to set the priorities for research into the psychological consequences of stroke in the UK.
Problems of mood, thinking and memory are common after a stroke. There has been limited research around these issues. This work aims to answer fundamental questions around who develops these problems and how they recover.
The purpose of this research is to adapt an existing group psychological support course to make it suitable for stroke.
This research aims to find out more about how thinking and mood are affected long-term after stroke, and the impact it has on people’s lives.
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.